The NIHR has funded the new “Stratification of Clinically Vulnerable People for COVID-19 Risk Using Antibody Testing (STRAVINSKY)” study. Researchers will find out if antibody testing can identify which immunosuppressed people remain at greatest risk of severe COVID-19 infection after vaccinations. The study will focus on priority groups for COVID-19 treatments and vaccinations. This includes people who are immunocompromised and those who do not respond well to vaccination. COVID-19 infections have disproportionately affected this group. It will involve 3000 immunocompromised participants over two years. 2,600 participants will receive a finger-prick antibody test. And 400 will receive more detailed immune analyses. The post holder will become part of the team at based at Imperial, and oversee a retrospective meta-analysis of immune responses to COVID-19 vaccines across different immune compromised individuals. This work will be performed with statistical oversight from Dr Beth Stuart at Queen Mary, University of London.
Duties and responsibilities
The post holder will be based at the Hammersmith Hospital Campus of Imperial College London and will become an integral part of the Stravinsky Study team. This will involve (i) Joining the trial group meetings; (ii) performing a meta-anlysis; (iii) overseeing clinical research databases and (iv) supporting research associates and nurses with medical based queries.
We are looking for medical qualified candidates (GMC registered), who have an interest in undertaking clinical research. It is essential that you can work independently and collaboratively and have knowledge of research databases and clinical studies.
This position is part-time (2.5 days a week) and fixed-term until 31st May 2025. This role will be based at Imperial’s Hammersmith Campus.
As this post is exempt from the Rehabilitation of Offenders Act 1974, a satisfactory Disclosure and Barring Service (DBS) check, at the appropriate level, will be required for the successful candidate.
Should you require any further details on the role please contact: Michelle Willicombe – .
The College is a proud signatory to the San-Francisco Declaration on Research Assessment (DORA), which means that in hiring and promotion decisions, we evaluate applicants on the quality of their work, not the journal impact factor where it is published. For more information, see https://www.imperial.ac.uk/research-and-innovation/about-imperial-research/research-evaluation/
The College believes that the use of animals in research is vital to improve human and animal health and welfare. Animals may only be used in research programmes where their use is shown to be necessary for developing new treatments and making medical advances. Imperial is committed to ensuring that, in cases where this research is deemed essential, all animals in the College’s care are treated with full respect, and that all staff involved with this work show due consideration at every level.
We are committed to equality of opportunity, to eliminating discrimination and to creating an inclusive working environment for all. We therefore encourage candidates to apply irrespective of age, disability, marriage or civil partnership status, pregnancy or maternity, race, religion and belief, gender assignment, sex, or sexual orientation. We are an Athena SWAN Silver Award winner, a Disability Confident Leader and a Stonewall Diversity Champion.